Answers are grounded in this paper and cite their sources.
The in vitro activities of DX-619, des-fluoro(6) quinolone, against 1,208 clinical isolates were examined. DX-619 was particularly potent against staphylococci, including ciprofloxacin- and methicillin-resistant strains; the MIC at which 90% of the strains tested were inhibited was 0.5 μg/ml. In addition, DX-619 was also active against gram-negative bacteria.
No takes yet. Share an insight, caveat, or question.
Fujikawa et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: